Cargando…
Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease
BACKGROUND: Evidence from epidemiological, clinical and animal studies suggests a link may exist between low bone density and cardiovascular disease, with inflammatory mediators implicated in the pathophysiology of both conditions. This project examined whether supplementation with soy isoflavones (...
Autores principales: | Droke, Elizabeth A, Hager, Kelly A, Lerner, Megan R, Lightfoot, Stan A, Stoecker, Barbara J, Brackett, Daniel J, Smith, Brenda J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034375/ https://www.ncbi.nlm.nih.gov/pubmed/17825101 http://dx.doi.org/10.1186/1476-9255-4-17 |
Ejemplares similares
-
Soy isoflavones and virus infections
por: Andres, Aline, et al.
Publicado: (2009) -
Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones
por: Moorehead, Roger A.
Publicado: (2019) -
Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality
por: Fan, Yahui, et al.
Publicado: (2022) -
Combined effects of soy isoflavone and lecithin on bone loss in ovariectomized mice
por: Kim, Sang Baek, et al.
Publicado: (2021) -
Age of Postmenopause Women: Effect of Soy Isoflavone in Lipoprotein and Inflammation Markers
por: Barrasa, Gladys Roxana Rocha, et al.
Publicado: (2018)